Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome. [electronic resource]
By: Contributor(s): Producer: 20160908Description: omw067 p. digitalISSN:- 2053-8855
Publication Type: Case Reports; Journal Article
There are no comments on this title.
-
1
Elementary, my dear Watson.
by García-Saénz, Jose A -
2
Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer.
by García-Sáenz, Jose A -
3
Irinotecan in the treatment of elderly patients with advanced colorectal cancer.
by Sastre, Javier -
4
Trastuzumab associated with successive cytotoxic therapies beyond disease progression in metastatic breast cancer.
by García-Sáenz, José A -
5
Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease.
by Romero, Atocha -
6
Vinorelbine as a 96-hour continuous infusion in heavily pretreated patients with metastatic breast cancer: a cooperative study by the GEICAM group.
by Jara-Sánchez, Carlos -
7
Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
by García-Sáenz, José A -
8
Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma.
by García-Sáenz, José A -
9
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer.
by Saura, Cristina -
10
Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial.
by Ruiz-Pinto, Sara -
11
Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel.
by García García-Esquinas, Marta A -
12
Brain metastases in metastatic breast cancer patients receiving trastuzumab-based therapies.
by Puente Vázquez, Javier -
13
BRCA1 Alternative splicing landscape in breast tissue samples.
by Romero, Atocha -
14
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
by Llombart-Cussac, Antonio -
15
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
by Mesía, Ricard -
16
Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.
by Bachelot, Thomas -
17
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study.
by Ruiz-Borrego, Manuel -
18
Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
by González-Rivera, Milagros -
19
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
by González-Rivera, Milagros -
20
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.
by Ruiz-Pinto, Sara
Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome.
APA
Gomes R. Q. D., Dos Santos-Júnior A., Dias G. A. d. A. S. & Cais C. F. d. S. (20160908). Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome. : Oxford medical case reports.
Chicago
Gomes Rafael Quintes Ducasble, Dos Santos-Júnior Amilton, Dias Gabriel Augusto de Araujo Silva and Cais Carlos Filinto da Silva. 20160908. Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome. : Oxford medical case reports.
Harvard
Gomes R. Q. D., Dos Santos-Júnior A., Dias G. A. d. A. S. and Cais C. F. d. S. (20160908). Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome. : Oxford medical case reports.
MLA
Gomes Rafael Quintes Ducasble, Dos Santos-Júnior Amilton, Dias Gabriel Augusto de Araujo Silva and Cais Carlos Filinto da Silva. Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome. : Oxford medical case reports. 20160908.